Arax Advisory Partners’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
PRS
PWMAG
IA
HNB
BC
Arax Advisory Partners's EXAS Position: Q1 2026 in Review
Arax Advisory Partners sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 367 shares — an estimated $37.3K sold.
Arax Advisory Partners first reported a position in EXAS in Q3 2024 and held it in 6 quarters. The position peaked at $1.16M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.
- Arax Advisory Partners reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
- Arax Advisory Partners sold 367 Exact Sciences shares in Q1 2026, an estimated $37.3K.
- Arax Advisory Partners first reported a position in Exact Sciences in Q3 2024 and held it in 6 quarters.
- Arax Advisory Partners's Exact Sciences position peaked at $1.16M in Q3 2025.
- 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.
Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.